Latest filing published 04 Jun 2026 for Oncolytics Biotech Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of John Bearden McAdory in Oncolytics Biotech Inc. Altogether 3 filings, all relating to 1 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 4 June 2026 with a transaction in Oncolytics Biotech Inc. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations